CEO departures often send a signal of uncertainty in the market.
Shares recently dipped for three pharma companies — Alkermes, Bavarian Nordic and Sarepta Therapeutics — after they each announced their respective long-time chiefs were stepping aside.
But a change in course could also help them overcome short-term…